Head to Head Contrast: Anteris Technologies Global (NASDAQ:AVR) vs. Tenon Medical (NASDAQ:TNON)

Tenon Medical (NASDAQ:TNON) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, risk, valuation and profitability.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Tenon Medical and Anteris Technologies Global, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	1	0	2	0	2.33
Anteris Technologies Global	1	0	1	0	2.00

Tenon Medical currently has a consensus price target of $3.00, suggesting a potential upside of 270.83%. Anteris Technologies Global has a consensus price target of $15.00, suggesting a potential upside of 164.08%. Given Tenon Medical’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Tenon Medical is more favorable than Anteris Technologies Global.

Profitability

This table compares Tenon Medical and Anteris Technologies Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-396.26%	-409.04%	-114.60%
Anteris Technologies Global	-3,944.93%	-252.71%	-169.61%

Volatility & Risk

Tenon Medical has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, Anteris Technologies Global has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500.

Valuation and Earnings

This table compares Tenon Medical and Anteris Technologies Global”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$3.28 million	2.74	-$13.67 million	($1.77)	-0.46
Anteris Technologies Global	$2.70 million	86.67	-$76.29 million	($1.81)	-3.14

Tenon Medical has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

22.7% of Tenon Medical shares are owned by institutional investors. 0.3% of Tenon Medical shares are owned by company insiders. Comparatively, 4.5% of Anteris Technologies Global shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Tenon Medical beats Anteris Technologies Global on 10 of the 14 factors compared between the two stocks.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.